INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
12 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham
Birmingham, Alabama, United States
Active, not recruiting - Recruiting
- Massachusetts General Hospital
Boston, Massachusetts, United States
Isabel Arrillaga-Romany, MD PhDRecruiting - Mayo Clinic
Rochester, Minnesota, United States
Active, not recruiting - Columbia University Medical Center
New York, New York, United States
Active, not recruiting - Memorial Sloan Kettering Cancer Center
New York, New York, United States
Recruiting - Cleveland Clinic
Cleveland, Ohio, United States
Active, not recruiting - University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States
Recruiting - Lifespan / Rhode Island Hospital
Providence, Rhode Island, United States
Active, not recruiting - Ut Md Anderson Cancer Center
Houston, Texas, United States
Completed - Huntsman Cancer Institute
Salt Lake City, Utah, United States
Active, not recruiting - University of Virginia Health System
Charlottesville, Virginia, United States
Completed
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 9 Feb 2017
- Primary completion
- 1 Feb 2028
- Completion
- 30 Apr 2028
- Last update posted
- 10 Nov 2025
- Registered enrollment
- 460
- Registry id
- NCT02977780
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.